MIM
ARTV

MetLife Investment Management’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

MetLife Investment Management’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,733
Closed -$88K – 2830
2024
Q4 		$88K Hold
8,733
– – ﹤0.01% 2670
2024
Q3 		$135K Buy
+8,733
New +$135K ﹤0.01% 2493